Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia-Reference-Cited by-同舟云学术

Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia

Published:2022-02 Issue:2 Volume:10 Page:e257-e268
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Bashorun Adedapo O,Badjie Hydara Mariama,Adigweme Ikechukwu,Umesi Ama,Danso Baba,Johnson Njilan,Sambou Ngally Aboubacarr,Fofana Sidat,Kanu Francis J,Jeyaseelan Visalakshi,Verma Harish,Weldon William C,Oberste M Steven,Sutter Roland W,Jeffries David,Wathuo Miriam,Mach Ondrej,Clarke Ed

Funder

World Health Organization

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine;Macklin;Science,2020

2. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge;Hird;PLoS Pathog,2012

3. Vaccine-derived polioviruses;Burns;J Infect Dis,2014

4. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial;John;Lancet,2014

5. Polio eradication. Efficacy of inactivated poliovirus vaccine in India;Jafari;Science,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel oral poliovirus vaccine type 2 is an important eradication tool, but reaching every last child remains vital;The Lancet Infectious Diseases;2024-04

2. Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance;Pathogens;2024-03-04

3. Observational analysis of the immunogenicity and safety of various types of spinal muscular atrophy vaccines;Inflammopharmacology;2024-02-03

4. Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe;Vaccine: X;2024-01

5. Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms;Nature Communications;2023-12-14